Semliki forest virus as a vector: Pros and cons for its use in biopharmaceuticals production
Nenhuma Miniatura disponível
Data
2013-09-01
Autores
Núñez, Eutimio Gustavo Fernández [UNESP]
Jorge, Soraia Attie Calil
Astray, Renato Mancini
de Rezende, Alexandre Gonçalves
da Costa, Bruno Labate Vale
Monteiro, Daniella Cristina Ventini
Pereira, Carlos Augusto
Tonso, Aldo
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
The number of biopharmaceuticals for medical and veterinarian use produced in mammalian cells is increasing year after year. All of them are obtained by stable recombinant cell lines. However, it is recognized that transient gene expression produces high level expression in a short time. In that sense, viral vectors have been extensively used for producing recombinant proteins on lab-scale. Among them, Semliki Forest virus is commonly employed for this purpose. This review discusses the main aspects related to the use of Semliki Forest virus technology as well as its advantages and drawbacks which limit currently its utilization in biopharmaceutical industry on large-scale.
Descrição
Palavras-chave
BHK-21, Large-scale bioprocesses, Mammalian cells, Recombinant proteins, SFV, Transient expression
Como citar
Brazilian Archives of Biology and Technology, v. 56, n. 5, p. 859-866, 2013.